Developing novel drugs against targets inside nerve cells to treat CNS disorders. Includes therapeutic projects, target biochemistry, corporate data and contacts for headquarters in New York City.
Intra-Cellular Therapies, Inc.
IntraCellular Therapies Home Page
2024-08-22
Intracellular Therapies, Inc. (ITI) is developing novel drugs for the treatment of depression, schizophrenia, Parkinson1s and Alzheimer1s disease and other Central Nervous System (CNS) disorders, based on proprietary targets identified and validated in vivo.